Psychiatry Investig.  2018 Oct;15(10):1007-1008. 10.30773/pi.2018.09.06.

Differences in High Dose Antipsychotic Prescriptions in Patients with Schizophrenia in Asian Countries/Areas: Findings from the REAP-AP Study

Affiliations
  • 1Department of Neuropsychiatry, Hanyang University Guri Hospital, Guri, Republic of Korea.
  • 2Deparment of Pharmacy, Songde Branch, Tapei City Hospital, Tapei, Taiwan.
  • 3Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University School of Medicine, Kaohsiung, Taiwan.
  • 4Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • 5Association for the Improvement of Mental Health Programs, Geneva, Switzerland.
  • 6Department of Social Welfare, School of Human Sciences, Seinan Gakuin University, Fukuoka, Japan.
  • 7Department of Pharmacology, National University Hospital, Singapore.
  • 8Department of Psychiatry, Inje University College of Medicine and Haeundae Paik Hospital, Busan, Republic of Korea. cogito-ergo-sum@hanmail.net

Abstract

The REAP-AP study recruited 3,746 patients with schizophrenia, in March and April 2016, from 71 centers in 15 Asian countries/territories namely Bangladesh, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Myanmar, Pakistan, Singapore, Sri Lanka, Taiwan, Thailand and Vietnam. Our findings reveal a trend according to which high dose antipsychotic prescription is more prevalent in Eastern Asia (especially, Japan and Korea) than in other regions of Asia. This historical factor may be associated with our finding of an Eastern Asian preponderance of high dose antipsychotic prescription.

Keyword

Asian; Antipsychotic; High dose; Schizophrenia

MeSH Terms

Asia
Asian Continental Ancestry Group*
Bangladesh
China
Far East
Hong Kong
Humans
India
Indonesia
Japan
Korea
Malaysia
Myanmar
Pakistan
Prescriptions*
Schizophrenia*
Singapore
Sri Lanka
Taiwan
Thailand
Vietnam
Full Text Links
  • PI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr